Author Correction: Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C

Tang, JuanjieNovak, TanyaHecker, JulianGrubbs, GabrielleZahra, Fatema TuzBellusci, LorenzaPourhashemi, SaraChou, JanetMoffitt, KristinHalasa, Natasha B.Schwartz, Stephanie P.Walker, Tracie C.Tarquinio, Keiko M.Zinter, Matt S.Staat, Mary A.Gertz, Shira J.Cvijanovich, Natalie Z.Schuster, Jennifer E.Loftis, Laura L.Coates, Bria M.Mack, Elizabeth H.Irby, KatherineFitzgerald, Julie C.Rowan, Courtney M.Kong, MicheleFlori, Heidi R.Maddux, Aline B.Shein, Steven L.Crandall, HillaryHume, Janet R.Hobbs, Charlotte V.Tremoulet, Adriana H.Shimizu, ChisatoBurns, Jane C.Chen, Sabrina R.Moon, Hye KyungLange, ChristophRandolph, Adrienne G.Khurana, Surender2023-08-032023-08-032022-08-12Tang J, Novak T, Hecker J, et al. Author Correction: Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C. Nat Commun. 2022;13(1):4732. Published 2022 Aug 12. doi:10.1038/s41467-022-32572-xhttps://hdl.handle.net/1805/34711Correction to: Nature Communications 10.1038/s41467-022-30649-1, published online 27 May 2022en-USAttribution 4.0 InternationalViral infectionSARS-CoV-2AntibodiesVaccinesAuthor Correction: Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-CArticle